News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
550,773 Results
Type
Article (40453)
Company Profile (81)
Press Release (510239)
Multimedia
Podcasts (47)
Webinars (11)
Section
Business (153466)
Career Advice (2436)
Deals (27881)
Drug Delivery (98)
Drug Development (73072)
Employer Resources (141)
FDA (13681)
Job Trends (12305)
News (273288)
Policy (27121)
Tag
Academia (2592)
Academic (1)
Accelerated approval (5)
Adcomms (26)
Allergies (80)
Alliances (39067)
ALS (95)
Alzheimer's disease (1396)
Antibody-drug conjugate (ADC) (133)
Approvals (13672)
Artificial intelligence (243)
Autoimmune disease (23)
Automation (16)
Bankruptcy (311)
Best Places to Work (10057)
BIOSECURE Act (15)
Biosimilars (91)
Biotechnology (65)
Bladder cancer (80)
Brain cancer (26)
Breast cancer (273)
Cancer (2188)
Cardiovascular disease (189)
Career advice (2048)
Career pathing (32)
CAR-T (146)
Cell therapy (405)
Cervical cancer (17)
Clinical research (59694)
Collaboration (733)
Company closure (2)
Compensation (289)
Complete response letters (22)
COVID-19 (2483)
CRISPR (41)
C-suite (261)
Cystic fibrosis (84)
Data (2202)
Decentralized trials (2)
Denatured (8)
Depression (52)
Diabetes (260)
Diagnostics (5762)
Digital health (14)
Diversity (4)
Diversity, equity & inclusion (38)
Drug discovery (112)
Drug pricing (95)
Drug shortages (23)
Duchenne muscular dystrophy (92)
Earnings (55264)
Editorial (38)
Employer branding (18)
Employer resources (128)
Events (75615)
Executive appointments (731)
FDA (14910)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (676)
Gene editing (104)
Generative AI (19)
Gene therapy (307)
GLP-1 (700)
Government (4175)
Grass and pollen (5)
Guidances (126)
Healthcare (16087)
Huntington's disease (24)
IgA nephropathy (29)
Immunology and inflammation (130)
Indications (27)
Infectious disease (2629)
Inflammatory bowel disease (135)
Inflation Reduction Act (8)
Influenza (53)
Intellectual property (90)
Interviews (524)
IPO (12596)
IRA (41)
Job creations (2627)
Job search strategy (1676)
Kidney cancer (11)
Labor market (22)
Layoffs (426)
Leadership (23)
Legal (5774)
Liver cancer (73)
Lung cancer (323)
Lymphoma (147)
Machine learning (7)
Management (51)
Manufacturing (269)
MASH (78)
Medical device (10718)
Medtech (10722)
Mergers & acquisitions (15787)
Metabolic disorders (678)
Multiple sclerosis (79)
NASH (23)
Neurodegenerative disease (101)
Neuropsychiatric disorders (31)
Neuroscience (1951)
NextGen: Class of 2025 (5573)
Non-profit (4035)
Now hiring (32)
Obesity (349)
Opinion (212)
Ovarian cancer (75)
Pain (89)
Pancreatic cancer (85)
Parkinson's disease (147)
Partnered (17)
Patents (226)
Patient recruitment (109)
Peanut (42)
People (51366)
Pharmaceutical (22)
Pharmacy benefit managers (11)
Phase I (18400)
Phase II (26262)
Phase III (20012)
Pipeline (1261)
Policy (139)
Postmarket research (2316)
Preclinical (7544)
Press Release (59)
Prostate cancer (100)
Psychedelics (37)
Radiopharmaceuticals (216)
Rare diseases (364)
Real estate (4202)
Recruiting (56)
Regulatory (19207)
Reports (26)
Research institute (2190)
Resumes & cover letters (357)
Rett syndrome (5)
RNA editing (3)
RSV (40)
Schizophrenia (76)
Series A (119)
Series B (78)
Service/supplier (4)
Sickle cell disease (52)
Special edition (11)
Spinal muscular atrophy (146)
Sponsored (28)
Startups (2808)
State (2)
Stomach cancer (14)
Supply chain (60)
Tariffs (36)
The Weekly (38)
Vaccines (654)
Venture capitalists (32)
Weight loss (232)
Women's health (26)
Worklife (17)
Date
Today (210)
Last 7 days (798)
Last 30 days (2635)
Last 365 days (28482)
2025 (10063)
2024 (30711)
2023 (34273)
2022 (44765)
2021 (48056)
2020 (46609)
2019 (39953)
2018 (30341)
2017 (27297)
2016 (25969)
2015 (30348)
2014 (22757)
2013 (18550)
2012 (19741)
2011 (20787)
2010 (18454)
Location
Africa (727)
Alabama (49)
Alaska (4)
Arizona (144)
Arkansas (11)
Asia (33907)
Australia (7065)
California (5234)
Canada (1838)
China (480)
Colorado (231)
Connecticut (221)
Delaware (140)
Europe (75896)
Florida (833)
Georgia (181)
Idaho (48)
Illinois (470)
India (23)
Indiana (278)
Iowa (7)
Japan (158)
Kansas (93)
Kentucky (19)
Louisiana (9)
Maine (50)
Maryland (798)
Massachusetts (3723)
Michigan (198)
Minnesota (313)
Mississippi (1)
Missouri (77)
Montana (21)
Nebraska (22)
Nevada (60)
New Hampshire (64)
New Jersey (1559)
New Mexico (21)
New York (1522)
North Carolina (803)
North Dakota (5)
Northern California (2295)
Ohio (173)
Oklahoma (5)
Oregon (25)
Pennsylvania (1175)
Puerto Rico (13)
Rhode Island (27)
South America (995)
South Carolina (22)
South Dakota (1)
Southern California (2028)
Tennessee (83)
Texas (809)
United States (19785)
Utah (173)
Virginia (140)
Washington D.C. (52)
Washington State (481)
West Virginia (3)
Wisconsin (42)
550,773 Results for "alliqua biomedical formerly known as alliqua".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Breast cancer
AstraZeneca, Daiichi Sankyo’s ADC Wins First Approval Despite Mixed Data
Datroway, formerly known as Dato-DXd, significantly improved median progression-free survival in a Phase III study but failed to do so for overall survival.
January 21, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Celltrion’s Remdantry™, previously known as Inflectra®, will be available in Canada as of April 1, 2025
March 27, 2025
·
3 min read
Press Releases
Clearside Biomedical’s Asia-Pacific Partner, Arctic Vision, Announced Acceptance of its New Drug Application for ARCATUS® for Regulatory Review in China for the Treatment of Uveitic Macular Edema
February 21, 2025
·
6 min read
Editorial
Biomedical Innovation in Jeopardy as Kennedy Distorts, Denies Scientific Truths
As the Trump administration—including HHS Secretary Robert F. Kennedy Jr.—plays fast and loose with scientific studies and facts, there may be a more sinister force at play: censorship.
May 2, 2025
·
6 min read
·
Heather McKenzie
Press Releases
Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer
April 14, 2025
·
5 min read
Press Releases
Clearside Biomedical Announces Six Abstracts Accepted for Presentation at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting
March 25, 2025
·
7 min read
Press Releases
Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference
April 23, 2025
·
1 min read
Press Releases
electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid Withdrawal
February 27, 2025
·
4 min read
Press Releases
Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing
Company executives will host a corporate webinar for investors and stakeholders on Thursday, April 10, 2025
March 31, 2025
·
12 min read
1 of 55,078
Next
